Cryopreservation of Ovarian Tissue
Launched by WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY · Mar 19, 2012
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a method called cryopreservation, which involves freezing ovarian tissue to help women who are at risk of losing their fertility due to cancer treatments or medical conditions. The goal is to improve techniques for freezing and thawing this tissue and maturing immature eggs in a lab, so that women can have a chance to conceive a child that is genetically related to them in the future.
Women between the ages of 0 and 45 who are premenopausal and are facing treatments that may cause premature menopause, such as certain types of cancer therapies or surgeries that involve removing the ovaries, may be eligible to participate. Participants will undergo a surgical procedure to take a small piece of ovarian tissue, which will then be frozen for potential future use. It's important that participants are in good health and have received medical clearance for the surgery. This trial is currently recruiting participants, so if you or someone you know fits the criteria and is interested in preserving fertility, this could be a valuable opportunity.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Females 0-45 years of age who are premenopausal
- • Treatment plan that will likely result in premature menopause or premature ovarian failure
- * This includes patients receiving:
- • Cancer treatment with abdominal pelvic irradiation and/or high dose chemotherapy
- • Surgery that requires removal of ovaries for medical condition or disease, e.g. Prophylactic oophorectomy in BRCA patients
- • Patient is unable or unwilling to pursue fertility preservation by freezing oocytes or embryos.
- • Previous treatment for cancer is acceptable if patient still has ovarian function
- • Patient is medically stable enough to undergo surgery (cleared for anesthesia)
- Exclusion Criteria:
- • Patients not meeting the above criteria
- • Patients who have not received medical clearance from their physicians to undergo surgery
- • Patients already experiencing menopause.
About Weill Medical College Of Cornell University
Weill Medical College of Cornell University is a leading academic institution dedicated to advancing medical research and education. As a prominent sponsor of clinical trials, it focuses on innovative healthcare solutions and the development of new therapies across various medical disciplines. The institution is committed to fostering collaborative research efforts that enhance patient care and improve health outcomes. With a robust infrastructure and a team of experienced researchers and clinicians, Weill Cornell aims to translate scientific discoveries into practical applications, ensuring a strong emphasis on ethical standards and regulatory compliance throughout the clinical trial process.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Patients applied
Trial Officials
Glenn Schattman, MD
Principal Investigator
Weill Medical College of Cornell University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials